July 18 (Reuters) - 9 Meters Biopharma said the drug developer and its unit have filed for Chapter 11 bankruptcy protection, according to a regulatory filing on Tuesday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
25/03 | North American Morning Briefing : Tech in Focus on -2- | DJ |
2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 14 | |
+197.71% | 7.18B | |
+2.10% | 982M | |
+41.91% | 872M | |
+26.33% | 806M | |
+1.82% | 664M | |
+6.82% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- NMTRQ Stock
- News 9 Meters Biopharma, Inc.
- Drug developer 9 Meters Biopharma files for bankruptcy protection